Copertina

Exploring drug mechanisms through single‐cell proteomics

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Yuzhi Sun, Renjie Liu, Jichong Mu, Liyuan Zhang, Yadong Wang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	British Journal of Pharmacology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Exploring the link between antihypertensive drugs targets and pancreatitis risk through Mendelian randomization
di: Zhiwei Du, et al.
Pubblicazione: (2025)

Advancing antihypertensive drug development
di: Fay Pu, et al.
Pubblicazione: (2025)

Elucidating the beneficial impact of exercise on chronic obstructive pulmonary disease and its comorbidities: Integrating proteomic and immunological insights
di: Xishuai Wang, et al.
Pubblicazione: (2024)

Assessment of the molecular mechanisms of drug‐induced hidden cardiotoxicity by a multi‐omics approach: The example of rofecoxib
di: Bennet Y. Weber, et al.
Pubblicazione: (2025)

Silencing drug transporters in human primary muscle cells modulates atorvastatin pharmacokinetics: A pilot study
di: Emilia Hoste, et al.
Pubblicazione: (2025)

Targeted peptide‐modified M2 exosomes drug delivery system for the targeted regulation of the lung injury microenvironment with isorhynchophylline (IRN): based on the inflammatory–metabolic–epigenetic synergy mechanism
di: Jin‐Ru Zou, et al.
Pubblicazione: (2026)

Circumventing glioblastoma resistance to temozolomide through optimal drug combinations designed by systems pharmacology and machine learning
di: Sergio Corridore, et al.
Pubblicazione: (2025)

Therapeutic drug monitoring of antimicrobials in a paediatric setting: A retrospective single‐centre study
di: Gianluca Gazzaniga, et al.
Pubblicazione: (2026)

Systematic drug screening and target analysis identify digitoxin as a potential therapy for uveal melanoma
di: Huilin Liu, et al.
Pubblicazione: (2024)

Exploring the complexities of drug formulation selection, storage, and shelf‐life for exploration spaceflight
di: Vernie R. Daniels, et al.
Pubblicazione: (2024)

Polypharmacy in mice disrupts left ventricular function and structure and promotes proteome reorganisation in an age‐ and sex‐specific fashion
di: Trang Tran, et al.
Pubblicazione: (2025)

A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
di: Dongdong Zhang, et al.
Pubblicazione: (2025)

Imperatorin ameliorates metabolic dysfunction‐associated fatty liver disease through modulating Suv39h1/Fabps/Cept1 signalling pathway
di: Yi Sun, et al.
Pubblicazione: (2025)

CKLF‐like MARVEL transmembrane domain‐containing superfamily 8 (CMTM8) promotes Notch signalling to maintain CD8 + T cell‐ and NK cell‐dependent tumour immune escape
di: Fanglin Li, et al.
Pubblicazione: (2026)

Emerging therapeutic opportunities for psychedelic and related drugs
di: Susan Wonnacott, et al.
Pubblicazione: (2026)

Opportunities of patient‐derived organoids in drug development
di: Antonia Büning, et al.
Pubblicazione: (2025)

Genetic polymorphisms influencing antihypertensive drug responses
di: Jana El Cheikh, et al.
Pubblicazione: (2024)

Chemistry/structural biology of psychedelic drugs and their receptor(s)
di: Ryan H. Gumpper, et al.
Pubblicazione: (2024)

SCA44‐ and SCAR13‐associated GRM1 mutations affect metabotropic glutamate receptor 1 function through distinct mechanisms
di: Yuyang Wang, et al.
Pubblicazione: (2024)

EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding
di: Ida M. Heerfordt, et al.
Pubblicazione: (2025)

CircPTK2 enhances non‐small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1
di: Qiuhui Li, et al.
Pubblicazione: (2025)

Correction to “Genetic polymorphisms influencing antihypertensive drug responses”
Pubblicazione: (2025)

The eyes of the beholder: Perceived barriers to successful drug repurposing
di: Zsuzsanna Ida Petykó, et al.
Pubblicazione: (2025)

P2X7 receptor‐dependent increase in endocannabinoid 2‐arachidonoyl glycerol production by neuronal cells in culture: Dynamics and mechanism
di: Simar Singh, et al.
Pubblicazione: (2024)

Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450
di: Vivek S. Purohit, et al.
Pubblicazione: (2025)

α‐Linolenic acid suppresses Th17 cell differentiation to mitigate allergic rhinitis by binding to Lyn kinase in mast cells
di: Yuejin Wang, et al.
Pubblicazione: (2026)

Insight into the regulatory mechanism of β‐arrestin2 and its emerging role in diseases
di: Meng Qi, et al.
Pubblicazione: (2024)

Identification of drug repurposing candidates for the treatment of polycystic kidney disease
di: Alina Meyer, et al.
Pubblicazione: (2026)

Natural products and cancer: From drug discovery to prevention and therapy
di: Angelo A. Izzo, et al.
Pubblicazione: (2025)

Artificial intelligence streamlines scientific discovery of drug–target interactions
di: Yuxin Yang, et al.
Pubblicazione: (2025)

Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review
di: Stavros Topouzis, et al.
Pubblicazione: (2025)

Cannabigerol reverses mechanical allodynia through α 2A ‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy
di: Quinn W. Wade, et al.
Pubblicazione: (2025)

Transient receptor potential ankyrin 1 channel modulates the abuse‐related mechanisms of methamphetamine through interaction with dopamine transporter
di: Kwang‐Hyun Hur, et al.
Pubblicazione: (2024)

Repurposing SGLT2 and DPP‐4 inhibitors for mild cognitive impairment in type 2 diabetes mellitus: Insights from proteomics, target prediction and molecular docking
di: Shams T. Osman, et al.
Pubblicazione: (2026)

Drug‐likeness evaluation and inhibitory mechanism of the emodin derivative on cardiac fibrosis based on metastasis‐associated protein 3
di: Heng Liu, et al.
Pubblicazione: (2025)

Rhynchophylline as an agonist of sirtuin 3 ameliorates endothelial dysfunction via antagonizing mitochondrial damage of endothelial progenitor cells
di: Lin Lin, et al.
Pubblicazione: (2025)

Clu + transitional alveolar epithelial cells promote lung injury repair and fibrosis progression
di: Yuquan Wang, et al.
Pubblicazione: (2026)

Clinical characteristics and risk factors for antituberculosis drug‐induced hypersensitivity
di: Quanxian Liu, et al.
Pubblicazione: (2024)

2‐Hydroxyl hispolon reverses high glucose‐induced endothelial progenitor cell dysfunction through the PI3K/Akt/eNOS and AMPK/HO‐1 pathways
di: Ta‐Jung Wang, et al.
Pubblicazione: (2025)

System level network data and models attack cancer drug resistance
di: Márk Kerestély, et al.
Pubblicazione: (2025)